Arcellx (ACLX) Accumulated Depreciation (2021 - 2025)
Arcellx's quarterly Accumulated Depreciation came in at $15.7 million in Q4 2025, up 66.74% year-on-year from $9.4 million in Q4 2024, and up 66.74% quarter-over-quarter from $9.4 million in Q4 2024.
Arcellx has reported Accumulated Depreciation for 5 years, with the latest figure at $15.7 million in Q4 2025.
- For the quarter ending Q4 2025, Accumulated Depreciation rose 66.74% year-over-year to $15.7 million; the trailing twelve-month figure through Dec 2025 stood at $15.7 million (up 66.74% YoY), and the FY2025 full-year result was $15.7 million, up 66.74% from the prior year.
- Accumulated Depreciation for Q4 2025 stood at $15.7 million, up from $9.4 million in the prior quarter.
- The five-year high for Accumulated Depreciation was $15.7 million in Q4 2025, with the low at $2.2 million in Q4 2021.
- Average Accumulated Depreciation over 5 years is $7.2 million, with a median of $5.3 million recorded in 2023.
- Year-over-year, Accumulated Depreciation surged 51.78% in 2023 and soared 79.78% in 2024.
- Tracing ACLX's Accumulated Depreciation over 5 years: stood at $2.2 million in 2021, then jumped by 60.08% to $3.5 million in 2022, then jumped by 51.78% to $5.3 million in 2023, then soared by 79.78% to $9.4 million in 2024, then surged by 66.74% to $15.7 million in 2025.
- The last three Accumulated Depreciation figures came in at $15.7 million (Q4 2025), $9.4 million (Q4 2024), and $5.3 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15.75 Mn |
| Dec 31, 2024 | 9.44 Mn |
| Dec 31, 2023 | 5.25 Mn |
| Dec 31, 2022 | 3.46 Mn |
| Dec 31, 2021 | 2.16 Mn |